News & Updates

Increased consumption of milk helps lower blood pressure levels and reduce the risk of developing hypertension, according to a study.

The time in target rage (TTR) of systolic blood pressure (SBP) appears to be predictive in assessing the risk of cardiovascular death in patients with nonvalvular atrial fibrillation (NVAF), reports a recent study.

Treatment with the sodium‐glucose cotransporter 2 inhibitor canagliflozin protects against cardiovascular events in patients with comorbid type 2 diabetes (T2D) and chronic kidney disease (CKD), with a larger absolute benefit for total cardiovascular than first cardiovascular events, according to a post hoc analysis.

The extent of extravalvular cardiac damage at baseline and its change at 1 year provide significant prognostic implications in patients undergoing aortic valve replacement (AVR), suggests a study.

Asians with atrial fibrillation (AF) or atrial flutter (AFL) do well with dronedarone, which lowers the risk of hospitalization for cardiovascular (CV) events or death from any cause to a similar extent as in non-Asian patients from the ATHENA trial, according to the results of a post hoc analysis.

An inverse, independent, and graded association exists between cardiorespiratory fitness (CRF) and mortality risk across the spectra of age, sex, and race, a recent study has found. In addition, there is no risk increase seen among extremely fit individuals.